Diabetic retinopathy in patients with type 1 diabetes treated with insulin glargine or NPH

被引：0

|

作者：

Peters, K

Garg, SK

JAckson, WE

Mackenzie, T

Queen, J

Anil, S

Chase, HP

机构：

来源：

DIABETES | 2001年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A443 / A443

页数：1

相关论文

共 50 条

[1] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
Garg, SK
Chase, HP
Marshall, G
[J]. DIABETES, 2001, 50 : A435 - A436
[2] Insulin glargine versus NPH insulin in patients with type 1 diabetes
Ratner, R
[J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
[3] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
Dailey, G. E.
Gao, L.
Aurand, L.
Garg, S. K.
[J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
[4] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
Dailey, G.
Aurand, L.
Garg, S.
[J]. DIABETOLOGIA, 2011, 54 : S262 - S262
[5] Similar progression of diabetic retinopathy with glargine or NPH insulin in type 2 diabetes (T2D)
Rosenstock, Julio
Fonseca, Vivian
McGill, Janet
Riddle, Matthew
Halle, Jean-Pierre
Hramiak, Irene
Johnston, Peter
Davis, Matthew
[J]. DIABETES, 2008, 57 : A86 - A86
[6] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
Nechevska, L.
Nechevski, M.
Nechevska, E.
Boskovski, B.
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[7] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
[J]. DIABETOLOGIA, 2004, 47 : A345 - A345
[8] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, Chang-Yu
Sinnassamy, Patrick
Chung, Kab-Do
Kim, Kwang-Won
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
[9] Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: A systematic review
Hagenmeyer E.-G.
Koltermann K.C.
Dippel F.-W.
Schädlich P.K.
[J]. Cost Effectiveness and Resource Allocation, 9 (1)
[10] Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
De Pablos, P
[J]. DIABETES, 2004, 53 : A291 - A292

← 1 2 3 4 5 →